0001127602-20-023248.txt : 20200810
0001127602-20-023248.hdr.sgml : 20200810
20200810161827
ACCESSION NUMBER: 0001127602-20-023248
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200807
FILED AS OF DATE: 20200810
DATE AS OF CHANGE: 20200810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith David Ross
CENTRAL INDEX KEY: 0001650274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15943
FILM NUMBER: 201089616
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE STREET
CITY: WILMINGTON
STATE: MA
ZIP: 01887
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CENTRAL INDEX KEY: 0001100682
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 061397316
FISCAL YEAR END: 1226
BUSINESS ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 781-222-6000
MAIL ADDRESS:
STREET 1: 251 BALLARDVALE ST
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC
DATE OF NAME CHANGE: 20000605
FORMER COMPANY:
FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19991208
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-08-07
0001100682
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL
0001650274
Smith David Ross
251 BALLARDVALE STREET
WILMINGTON
MA
01887
1
Corporate Executive VP & CFO
Common Stock
2020-08-07
4
M
0
3304
144.67
A
24071
D
Common Stock
2020-08-07
4
S
0
2297
216.4169
D
21774
D
Common Stock
2020-08-07
4
S
0
1007
216.8165
D
20767
D
Stock Options (Right to Buy)
144.67
2020-08-07
4
M
0
3304
0
D
2020-02-22
2024-02-22
Common Stock
3304
9914
D
This transaction was executed in multiple trades at prices ranging from $215.72 to $216.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $216.72 to $216.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ David R. Smith
2020-08-10